ATLANTA, Nov. 06, 2017 -- On October 31, 2017, at its regular quarterly meeting, the Board of Directors of Crawford & Company® declared a quarterly dividend of $0.07 per share on the Class A Common Stock and $0.05 per share on the Class B Common Stock, payable on December 7, 2017, to shareholders of record as of the close of business on November 21, 2017. The Company’s two classes of stock are substantially identical, except with respect to voting rights and the Company’s ability to pay greater cash dividends on the non-voting Class A Common Stock than on the voting Class B Common Stock, subject to certain limitations. In addition, with respect to mergers or similar transactions, holders of Class A Common Stock must receive the same type and amount of consideration as holders of Class B Common Stock, unless different consideration is approved by the holders of 75% of the Class A Common Stock, voting as a class.
A PDF accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/43ecc41a-9f23-41d7-abab-5965bdfec3a7
About Crawford®
Based in Atlanta, Crawford & Company (NYSE:CRD‐A) and (NYSE:CRD‐B) is the world’s largest publicly listed independent provider of claims management solutions to insurance companies and self‐insured entities with an expansive global network serving clients in more than 70 countries. The Company’s two classes of stock are substantially identical, except with respect to voting rights and the Company’s ability to pay greater cash dividends on the non-voting Class A Common Stock (CRD-A) than on the voting Class B Common Stock (CRD-B), subject to certain limitations. In addition, with respect to mergers or similar transactions, holders of CRD-A must receive the same type and amount of consideration as holders of CRD-B, unless different consideration is approved by the holders of 75% of CRD-A, voting as a class. More information is available at www.crawfordandcompany.com.
For further information regarding this press release, please call Bruce Swain at (404) 300-1051.


Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval
Russia Moves to Fully Block WhatsApp as Kremlin Pushes State-Backed MAX App
Westpac (ASX: WBC) Q1 Profit Rises 6% as Lending Growth and Treasury Income Strengthen Earnings
Paramount Skydance Appoints Rene Augustine as SVP of Global Public Policy Amid Warner Bros Takeover Battle
Boeing Reports Major Supply Chain Quality Improvements After Spirit AeroSystems Deal
U.S. Judge Allows Jeffrey Epstein Sex Trafficking Lawsuit Against Bank of America to Proceed
ByteDance Advances AI Chip Development With Samsung Manufacturing Talks
FTC Questions Apple News Over Alleged Bias Against Conservative Media
Anduril Eyes $60 Billion Valuation in New Funding Round to Expand Defense Manufacturing and Autonomous Fighter Jet Development
How Marco Pharma International Preserves German Homeopathic Traditions in America
Lockheed Martin Secures $101M in U.S. Defense Contracts for AEGIS, F-35, and Missile Systems
Gates Foundation Denies Financial Ties to Jeffrey Epstein Following DOJ Email Release
Instagram CEO Defends Platform in Youth Mental Health Lawsuit Over Social Media Addiction Claims
Sachem Head Boosts Warner Bros. Discovery Stake Amid Netflix Deal and Paramount Bid
Spirit Airlines Seeks Court Approval to Auction 20 Airbus A320/A321 Aircraft Amid Bankruptcy
Grok AI Market Share Surges as xAI Faces Scrutiny Over Image Generation Controversy
Bank of America CEO Brian Moynihan’s 2025 Compensation Rises 17% to $41 Million Amid Strong Profit Growth 



